Quoin Pharmaceuticals, LTD Form 4 insider transactions

Quoin Pharmaceuticals' Chief Operating Officer, Denise P. Carter, has been granted share options exercisable at $0.78 per share, vesting over four years.

Quoin Pharmaceuticals has granted share options to Michael Sember, vesting over four years, with each option representing one ordinary share.

Quoin Pharmaceuticals CEO, Michael Myers, has been granted share options that vest over four years.

Natalie Leong, a director at Quoin Pharmaceuticals, acquired share options for 50,714 American Depositary Shares (ADS) on December 9, 2024.

Quoin Pharmaceuticals has granted share options to Dennis Langer, vesting over four years.

Gordon Dunn, CFO of Quoin Pharmaceuticals, recently acquired additional ordinary shares in the company through a series of transactions.

Denise Carter, COO of Quoin Pharmaceuticals, recently acquired additional ordinary shares in the company through a series of transactions.

CEO Michael Myers recently acquired additional ordinary shares of Quoin Pharmaceuticals, Ltd. through a series of transactions.

Director Dennis Langer reported the sale of 297 ordinary shares of Quoin Pharmaceuticals, represented by American Depositary Shares (ADSs), at a price of $0.732 on June 7, 2024.